ASPREE-D: Aspirin for the prevention of depression in the elderly
Copyright © International Psychogeriatric Association 2016. Background:: Not only is depression associated with increased inflammation but inflammation is a risk factor for the genesis of depression. Many of the environmental risk factors for depression are transduced through inflammatory signaling....
| Main Authors: | Berk, M., Woods, R., Nelson, M., Shah, R., Reid, Christopher, Storey, E., Fitzgerald, S., Lockery, J., Wolfe, R., Mohebbi, M., Murray, A., Kirpach, B., Grimm, R., McNeil, J. |
|---|---|
| Format: | Journal Article |
| Published: |
Cambridge University Press
2016
|
| Online Access: | http://hdl.handle.net/20.500.11937/19735 |
Similar Items
Baseline Characteristics of Participants in the ASPREE (Aspirin in Reducing Events in the Elderly) Study
by: McNeil, J., et al.
Published: (2019)
by: McNeil, J., et al.
Published: (2019)
Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study
by: McNeil, J., et al.
Published: (2017)
by: McNeil, J., et al.
Published: (2017)
Quality of Life for 19,114 participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study and their association with sociodemographic and modifiable lifestyle risk factors
by: Stocks, N., et al.
Published: (2018)
by: Stocks, N., et al.
Published: (2018)
Prevalence of chronic kidney disease in the elderly using the ASPirin in Reducing Events in the Elderly (ASPREE) study cohort
by: Polkinghorne, K., et al.
Published: (2019)
by: Polkinghorne, K., et al.
Published: (2019)
The aspirin in reducing events in the elderly trial: Statistical analysis plan
by: Wolfe, R., et al.
Published: (2018)
by: Wolfe, R., et al.
Published: (2018)
Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial
by: Berk, M., et al.
Published: (2020)
by: Berk, M., et al.
Published: (2020)
Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial
by: Grimm, R., et al.
Published: (2013)
by: Grimm, R., et al.
Published: (2013)
Effect of aspirin on disability-free survival in the healthy elderly
by: McNeil, J., et al.
Published: (2018)
by: McNeil, J., et al.
Published: (2018)
Slowing the progression of age-related hearing loss: Rationale and study design of the ASPIRIN in HEARING, retinal vessels imaging and neurocognition in older generations (ASPREE-HEARING) trial
by: Lowthian, J., et al.
Published: (2016)
by: Lowthian, J., et al.
Published: (2016)
Effect of aspirin on all-cause mortality in the healthy elderly
by: McNeil, J., et al.
Published: (2018)
by: McNeil, J., et al.
Published: (2018)
Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study
by: Robman, L., et al.
Published: (2017)
by: Robman, L., et al.
Published: (2017)
Effect of aspirin on cardiovascular events and bleeding in the healthy elderly
by: McNeil, J., et al.
Published: (2018)
by: McNeil, J., et al.
Published: (2018)
Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adults
by: Mohebbi, M., et al.
Published: (2017)
by: Mohebbi, M., et al.
Published: (2017)
Overcoming challenges to data quality in the ASPREE clinical trial
by: Lockery, J.E., et al.
Published: (2019)
by: Lockery, J.E., et al.
Published: (2019)
Genetic variation in PEAR1, cardiovascular outcomes and effects of aspirin in a healthy elderly population
by: Lewis, J.P., et al.
Published: (2020)
by: Lewis, J.P., et al.
Published: (2020)
Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial
by: Islam, R.M., et al.
Published: (2022)
by: Islam, R.M., et al.
Published: (2022)
A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial data
by: Neumann, J.T., et al.
Published: (2022)
by: Neumann, J.T., et al.
Published: (2022)
Aspirin for the prevention of cognitive decline in the elderly: Rationale and design of a neuro-vascular imaging study (ENVIS-ion)
by: Reid, Christopher, et al.
Published: (2012)
by: Reid, Christopher, et al.
Published: (2012)
Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.
by: Ryan, Joanne, et al.
Published: (2020)
by: Ryan, Joanne, et al.
Published: (2020)
Patterns of Association between Depressive Symptoms and Chronic Medical Morbidities in Older Adults
by: Agustini, B., et al.
Published: (2020)
by: Agustini, B., et al.
Published: (2020)
Normative performance of healthy older individuals on the Modified Mini-Mental State (3MS) examination according to ethno-racial group, gender, age, and education level
by: Ryan, J., et al.
Published: (2018)
by: Ryan, J., et al.
Published: (2018)
Association of depression with mortality in an elderly treated hypertensive population
by: Chowdhury, E., et al.
Published: (2018)
by: Chowdhury, E., et al.
Published: (2018)
The Study of Neurocognitive Outcomes, Radiological and Retinal Effects of Aspirin in Sleep Apnoea- rationale and methodology of the SNORE-ASA study
by: Ward, S., et al.
Published: (2018)
by: Ward, S., et al.
Published: (2018)
Trajectories of depressive symptoms in older adults and associated health outcomes
by: Agustini, B., et al.
Published: (2022)
by: Agustini, B., et al.
Published: (2022)
Effect of aspirin on cancer incidence and mortality in older adults.
by: McNeil, John J, et al.
Published: (2020)
by: McNeil, John J, et al.
Published: (2020)
The effect of depressive symptoms on disability-free survival in healthy older adults: A prospective cohort study
by: Roebuck, G., et al.
Published: (2023)
by: Roebuck, G., et al.
Published: (2023)
Factors associated with treatment and control of hypertension in a healthy elderly population free of cardiovascular disease: A Cross-sectional Study
by: Chowdhury, Enayet, et al.
Published: (2020)
by: Chowdhury, Enayet, et al.
Published: (2020)
Impact of the 2017 AmericanHeart Association and American College of Cardiology hypertension guideline in aged individuals
by: Chowdhury, Enayet, et al.
Published: (2020)
by: Chowdhury, Enayet, et al.
Published: (2020)
Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults
by: Zhou, Z., et al.
Published: (2020)
by: Zhou, Z., et al.
Published: (2020)
Aspirin decreases the risk of depression in older men with high plasma homocysteine
by: Almeida, O., et al.
Published: (2012)
by: Almeida, O., et al.
Published: (2012)
Aspirin use, depression, and cognitive impairment in later life: The health in men study
by: Almeida, O., et al.
Published: (2010)
by: Almeida, O., et al.
Published: (2010)
Protocol for a pilot randomised controlled clinical trial to compare the effectiveness of a graduated three layer straight tubular bandaging system when compared to a standard short stretch compression bandaging system in the management of people with venous ulceration: 3VSS2008
by: Weller, C., et al.
Published: (2010)
by: Weller, C., et al.
Published: (2010)
Simple Synthetic Receptors for Aspirin
by: Nguyen, Thanh Vinh, et al.
Published: (2014)
by: Nguyen, Thanh Vinh, et al.
Published: (2014)
Low Dose Aspirin Usage Among Elderly Australian Residential Aged Care Facility Residents
by: hie, S., et al.
Published: (2009)
by: hie, S., et al.
Published: (2009)
Twisted Aspirin Crystals
by: Cui, X., et al.
Published: (2013)
by: Cui, X., et al.
Published: (2013)
Social isolation, social support and loneliness as predictors of cardiovascular disease incidence and mortality
by: Freak-Poli, R., et al.
Published: (2021)
by: Freak-Poli, R., et al.
Published: (2021)
Dipyridamole plus aspirin versus aspirin alone in the secondary prevention after TIA or stroke: a meta-analysis by risk
by: Halkes, P.H.A., et al.
Published: (2008)
by: Halkes, P.H.A., et al.
Published: (2008)
Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
by: Zomer, E., et al.
Published: (2018)
by: Zomer, E., et al.
Published: (2018)
Selective binding and release of aspirin by an encapsulating receptor
by: Nguyen, Thanh Vinh, et al.
Published: (2010)
by: Nguyen, Thanh Vinh, et al.
Published: (2010)
The Medical Genome Reference Bank contains whole genome and phenotype data of 2570 healthy elderly
by: Pinese, M., et al.
Published: (2020)
by: Pinese, M., et al.
Published: (2020)
Similar Items
-
Baseline Characteristics of Participants in the ASPREE (Aspirin in Reducing Events in the Elderly) Study
by: McNeil, J., et al.
Published: (2019) -
Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study
by: McNeil, J., et al.
Published: (2017) -
Quality of Life for 19,114 participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study and their association with sociodemographic and modifiable lifestyle risk factors
by: Stocks, N., et al.
Published: (2018) -
Prevalence of chronic kidney disease in the elderly using the ASPirin in Reducing Events in the Elderly (ASPREE) study cohort
by: Polkinghorne, K., et al.
Published: (2019) -
The aspirin in reducing events in the elderly trial: Statistical analysis plan
by: Wolfe, R., et al.
Published: (2018)